ADMA Biologics
ADMA
ADMA
72 hedge funds and large institutions have $47.3M invested in ADMA Biologics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 24
78% less call options, than puts
Call options by funds: $473K | Put options by funds: $2.14M
Holders
72
Holding in Top 10
–
Calls
$473K
Puts
$2.14M
Top Buyers
| 1 | +$3.28M | |
| 2 | +$1.11M | |
| 3 | +$626K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$293K |
| 5 |
Morgan Stanley
New York
|
+$246K |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$479K | |
| 3 | -$475K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$414K |
| 5 |
Barclays
London,
United Kingdom
|
-$370K |